|
|
| About Manufacture of
Trileptal – Trileptal |
Trileptal-Oxcarbazepine has been manufactured by the United States
based Novartis Pharmaceuticals Corporation-NPC which is an affiliate
of Basel, Switzerland based Novartis AG. The headquarters of the
Novartis Pharmaceuticals Company are located at East Hanover, NJ and
is aimed to discover, develop and successfully market advanced
medications for curing ailments, easing suffering and improve the
quality of life. The company researches, develops and markets
foremost inventive prescription medications used for treating the
wide-range of disease areas such as the cardiovascular, respiratory
ailments, infectious diseases, neuroscience, bone and hormone
therapies, ophthalmology, transplantation and oncology/hematology.
The mission of Novartis is to enhance people’s lives by
ground-breaking marvelous healthcare solutions.
Novartis has dedicated reserves, strategies and devices to more
efficiently communicate, edify and apply its supplier multiplicity
program throughout its organization and across its supplier network.
The company has taken the directive position in improving the access
of less earning patients to the medications they require. Novartis
helps thousands of patients on day to day basis through its Novartis
Patient Assistance Program and Together Rx. The Novartis group
companies today employs more than 100,000 associates and operate in
more than 140 nations across all the continents of the world. The
NPC’s headquarter on the 200 acre campus at East Hanover, NJ employs
13,000 people at its three sites and in four regions through out the
United States.
Innovation is the heart of company’s research policy and aspires to
bind the most up-to-date progress in biomedical research and
technology for developing newer therapies with potential to benefit
millions of patients across the world. The company invests $5.3
billion per annum in world-wide research and developments.
|
|
